AI assistant
Smith & Nephew PLC — Director's Dealing 2019
May 7, 2019
4588_dirs_2019-05-07_fc11aaf7-7bee-489b-9012-14e05072ce7c.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 2507Y
Smith & Nephew Plc
07 May 2019
SMITH & NEPHEW PLC
7 May 2019
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Phil Cowdy
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Smith & Nephew plc
b)
LEI
213800ZTMDN8S67S1H61
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Smith & Nephew plc ordinary shares of USD 0.20 each
ISIN: GB0009223206
b)
Nature of the transaction
Sale of ordinary shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £15.845 | 4,696 |
d)
Aggregated information
- Aggregated volume
- Price
Single Transaction
N/A
N/A
e)
Date of the transaction
2019 - 05 - 07
f)
Place of the transaction
XLON
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: 01923 477216
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHLLFIFEEIDIIA